EMFO LLC’s Avenue Therapeutics, Inc. Common Stock ATXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $28 | Buy |
8
+1
| +14% | +$4 | ﹤0.01% | 281 |
|
|
2024
Q1 | $79 | Hold |
7
| – | – | ﹤0.01% | 285 |
|
|
2023
Q4 | $86 | Hold |
7
| – | – | ﹤0.01% | 278 |
|
|
2023
Q3 | $377 | Hold |
7
| – | – | ﹤0.01% | 290 |
|
|
2023
Q2 | $624 | Hold |
7
| – | – | ﹤0.01% | 295 |
|
|
2023
Q1 | $621 | Hold |
7
| – | – | ﹤0.01% | 299 |
|
|
2022
Q4 | $618 | Hold |
7
| – | – | ﹤0.01% | 287 |
|
|
2022
Q3 | $5K | Sell |
7
-7
| -50% | -$5K | ﹤0.01% | 293 |
|
|
2022
Q2 | $4K | Sell |
14
-7
| -33% | -$2K | ﹤0.01% | 305 |
|
|
2022
Q1 | $12K | Hold |
21
| – | – | 0.01% | 276 |
|
|
2021
Q4 | $22K | Sell |
21
-18
| -46% | -$18.9K | 0.02% | 244 |
|
|
2021
Q3 | $65K | Hold |
39
| – | – | 0.06% | 182 |
|
|
2021
Q2 | $109K | Buy |
+39
| New | +$109K | 0.1% | 139 |
|